Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T-cell activation for enhanced cancer vaccination
Preprint
- 20 March 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Dendritic cells (DCs) can process patient-derived antigens to generate extracellular vesicles (DEVs) vaccines, which can be personalized and rapidly adapted to the evolving antigenic profile in chronic diseases. These DEVs present antigens and stimulate T cell responses, but their clinical efficacy is limited by poorly understood mechanisms. This study reveals how DCs incorporate ancient viral genes to produce endogenous virus-like vesicles (VLVs) that enable long-range T cell communication. Overexpressing a viral capsid protein Arc and a capsid-stabilizer substantially boosted DEVs’ antigen-presentation capabilities and immune responses, whereas Arc-deficient DEVs failed to generate specific immune memory. Proteomic analysis revealed that engineered virus-like vesicles (eraVLVs) enhance antigen presentation on MHC-I, recruit viral proteins for direct T cell interaction, and act as built-in adjuvants to boost broad immune responses. Using a cancer vaccine platform independent of model-specific antigens, we demonstrated robust and broad anti-cancer efficacy, with eraVLVs substantially extending median survival.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Tumour-derived extracellular vesicle based vaccines for melanoma treatmentDrug Delivery and Translational Research, 2023
- Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccineBiomedicine & Pharmacotherapy, 2022
- Extracellular Vesicles and Their Roles in Cancer Progression2020
- Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 StudiesMolecular Diagnosis & Therapy, 2020
- Arc/Arg3.1 defines dendritic cells and Langerhans cells with superior migratory ability independent of phenotype and ontogeny in miceEuropean Journal of Immunology, 2019
- Evaluation of six sample preparation procedures for qualitative and quantitative proteomics analysis of milk fat globule membraneElectrophoresis, 2018
- Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I studyBreast Cancer Research and Treatment, 2017
- The HIV-1 Env Protein: A Coat of Many ColorsCurrent HIV/AIDS Reports, 2012
- Development of an integrated approach for evaluation of 2‐D gel image analysis: Impact of multiple proteins in single spots on comparative proteomics in conventional 2‐D gel/MALDI workflowElectrophoresis, 2007
- Direct exosome stimulation of peripheral humanT cells detected by ELISPOTEuropean Journal of Immunology, 2006